OpenBilldrug price receipt

NADAC week of 2026-10-14

BROMFENAC SODIUM 0.07% EYE DRP

For 3 mL

Pharmacies pay

$39.75 filed

3 × $13.24968 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$184.16 filed

3 × $61.38688 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

4.6× estimated

Medicare paid 4.6× what pharmacies pay.

Part D averages every strength and form sold under “Bromfenac Sodium” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$50.71 estimated

$39.75 + $5.96 (15%) + $5.00 fee per fill = $50.71

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BROMFENAC SODIUM 0.07% EYE DRP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as bromfenac sodium, under the trade names “Bromfenac Ophthalmic Solution, 0.07%” and “bromfenac ophthalmic solution”.

FDA gives its dosage form as solution/ drops and its route as ophthalmic.

FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Apotex Corp., Alembic Pharmaceuticals Inc. and Lupin Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Nonsteroidal Anti-inflammatory Drug.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $39.75 for 3 mL (3 × $13.24968 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 5 NDCs

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name bromfenac sodium with BROMFENAC SODIUM 0.07% EYE DRP.

ProductPharmacies pay per unitMedicare per unit
BROMFENAC SODIUM 0.07% EYE DRP this page
generic · solution/ drops
$13.24968 per ML filed
eff. 2026-09-23
$61.38688 per ML filed
Part D 2024 average
PROLENSA 0.07% EYE DROPS
brand · solution/ drops
$115.55435 per ML filed
eff. 2026-09-23
$114.28339 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 5 NDCs’ NADAC prices is $13.24968 per ML filed.

Of the 25 other products in FDA’s Nonsteroidal Anti-inflammatory Drug class priced per ML, 8 have a higher middle NADAC price and 17 a lower one. The one in the middle is KETOROLAC 30 MG/ML VIAL, at $1.01747 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $184.16 for 3 mL, at an average of $61.38688 per ML in 2024 (2024-01-01 to 2024-12-31) for “Bromfenac Sodium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 133,996 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for BROMFENAC SODIUM 0.07% EYE DRP labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Bromfenac Sodium / Bromfenac Sodium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
Why does this page start at 3 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 3 mL in one package for all 5 NDCs of this product (“1 BOTTLE, DROPPER in 1 CARTON (60505-1006-2) / 3 mL in 1 BOTTLE, DROPPER”), so the card starts at one package: 3 ML. Change it to match your prescription.